MedTrace Logo

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

NCT04890314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1953

Last updated 2025-05-22

Study results available
· View outcomes & findings →

Summary

This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, such as general health, urinary, sexual, and bowel function, cancer anxiety, and treatment regret will be compared and tracked over the course of this study.

Conditions

Interventions

OTHER

Patient-reported questionnaire

Validated questionnaires administered at baseline, 8 months following treatment, and 12 months following treatment.

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Jim Hu, MD MPH · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04890314 on ClinicalTrials.gov